- Home
- MP vs BAX Comparison
MP vs BAX Comparison
Compare MP & BAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MP
- BAX
- Stock Information
- Founded
- MP 2017
- BAX 1931
- Country
- MP United States
- BAX United States
- Employees
- MP N/A
- BAX N/A
- Industry
- MP Metal Mining
- BAX Medical/Dental Instruments
- Sector
- MP Basic Materials
- BAX Health Care
- Exchange
- MP Nasdaq
- BAX Nasdaq
- Market Cap
- MP 12.9B
- BAX 11.6B
- IPO Year
- MP N/A
- BAX N/A
- Fundamental
- Price
- MP $63.05
- BAX $24.43
- Analyst Decision
- MP Buy
- BAX Hold
- Analyst Count
- MP 8
- BAX 9
- Target Price
- MP $61.00
- BAX $32.00
- AVG Volume (30 Days)
- MP 11.2M
- BAX 6.9M
- Earning Date
- MP 08-07-2025
- BAX 07-31-2025
- Dividend Yield
- MP N/A
- BAX 2.78%
- EPS Growth
- MP N/A
- BAX N/A
- EPS
- MP N/A
- BAX N/A
- Revenue
- MP $242,116,000.00
- BAX $10,887,000,000.00
- Revenue This Year
- MP $41.97
- BAX $7.38
- Revenue Next Year
- MP $145.91
- BAX $3.78
- P/E Ratio
- MP N/A
- BAX N/A
- Revenue Growth
- MP 39.42
- BAX 3.60
- 52 Week Low
- MP $13.21
- BAX $21.33
- 52 Week High
- MP $82.50
- BAX $40.49
- Technical
- Relative Strength Index (RSI)
- MP 43.61
- BAX 47.13
- Support Level
- MP $68.74
- BAX $23.12
- Resistance Level
- MP $74.27
- BAX $24.72
- Average True Range (ATR)
- MP 4.02
- BAX 0.63
- MACD
- MP -1.84
- BAX 0.16
- Stochastic Oscillator
- MP 11.72
- BAX 73.73
About MP MP Materials Corp.
MP Materials Corp is the producer of rare earth materials in the Western Hemisphere. The company owns and operates the Mountain Pass Rare Earth Mine and Processing Facility, the only rare earth mining and processing site of scale in North America. The company is also developing a rare earth metal, alloy, and magnet manufacturing facility in Fort Worth, Texas. The company's operations are organized into two reportable segments: Materials and Magnetics.
About BAX Baxter International Inc.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.